Clinical trial
Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma
NCT00003445 is registered in ClinicalTrials.gov with Grupo Oncologico Cooperativo del Sur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma
- Lead sponsor
- Grupo Oncologico Cooperativo del Sur
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 1997
- Completion date
- April 30, 2004
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer